Provincial Variation in Adherence to Breast Cancer Screening in Canada: Evidence From the Canadian Partnership for Tomorrow's Health

加拿大各省乳腺癌筛查依从性差异:来自加拿大未来健康伙伴关系的证据

阅读:2

Abstract

BACKGROUND: Breast cancer is the most commonly diagnosed cancer among women in Canada. Screening is effective in reducing breast cancer mortality through early cancer detection. However, data on individual social and medical characteristics contributing to variation in adherence to screening is limited. METHODS: Using multivariable logistic regression, we analyzed self-reported questions on engagement in screening mammography from five regions of the Canadian Partnership for Tomorrow's Health (CanPath), including the BC Generations Project (BCGP), Alberta's Tomorrow Project (ATP), the Ontario Health Study (OHS), Quebec's CARTaGENE, and the Atlantic Partnership for Tomorrow's Health Study (Atlantic PATH). RESULTS: The study population included 79,986 and 46,907 individuals aged 50-74 and 40-49 years at study enrollment, respectively. Most participants self-reported undergoing screening mammography less than 2 years from study enrollment, ranging from 77.8% in OHS to 86.3% in BCGP. Factors significantly associated with a lower odd of ever undergoing screening mammography were lower household income, being single/never married, current daily smoking, poor self-perceived health, no history of breast feeding, and ≥ 24 months since last routine medical check-up by a doctor or nurse. Among women aged 40-49 years with a first-degree family history of breast cancer (N = 4212 [8.9%]), the likelihood of ever being screened varied by region and was significantly lower among individuals with post menopause and more than 12 months since last medical check-up. CONCLUSION: Factors associated with screening adherence that were identified in this study namely household income, self-perceived health, and routine medical check-ups should be considered as potential factors for targeting undeserved communities and increasing engagement in screening at both provincial and national levels. The observed variation in mammography among women aged 40 to 49 years with family history of breast cancer, may inform the current guidelines for potential benefits of early screening initiation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。